WHO turns attention to fungal infections as drug resistance builds
By
Alicia Lasek
Oct 26, 2022
The World Health Organization has created a first-ever priority list of fungi that it says pose the greatest emerging threats to public health.
Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...
Not all older adults can get monoclonal antibodies for Alzheimer’s disease, study finds
By
Kristen Fischer
Sep 22, 2023
Even though newer monoclonal antibodies are available for Alzheimer’s disease, there are limits on the number of older adults who can receive them, a recent study published in Neurology finds.
Report: Caregivers, healthcare workers struggle to navigate dementia care
By
Kristen Fischer
Mar 21, 2024
People caring for those with dementia — who include family members and healthcare workers — say it’s hard to navigate the disease within the US health system, according to the Alzheimer’s Association...
Risk of blood clots remains almost a year after COVID-19
By
Lori Baker
Sep 22, 2022
A large, new study published by the American Heart Association reveals the threat of blood clots leading to life-threatening strokes, heart attacks and pulmonary embolism can linger for nearly a year after...
Medicare Advantage retaining sicker patients with more complex health needs: study
By
Alicia Lasek
Jun 29, 2023
After years of criticism for cherry-picking healthier people for enrollment, Medicare Advantage is now holding onto more patients with chronic conditions, investigators say.
CDC Shortens Recommended COVID Isolation Period
Mar 01, 2024
New guidance issued Friday by the U.S. Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days.
Race, ethnicity help determine which controllable risk factors for dementia have biggest impacts
By
Kristen Fischer
Jan 18, 2024
Controllable risk factors that factor into Alzheimer’s or dementia cases play varying roles based on someone’s race and ethnicity, a new study shows.
FDA approves new drug Leqembi to treat early Alzheimer’s disease
By
Alicia Lasek
Jan 09, 2023
The newly approved drug Leqembi (lecanemab) may slow progression of cognitive decline due to Alzheimer’s disease, trial data show. CMS says it may rethink Medicare coverage of drugs in Leqembi’s...
SNFs have made great strides in preventing, treating COVID, docs say
By
Joe Bush
Oct 14, 2022
Nursing facilities are now highly skilled at preventing COVID-19 illness and staving off serious outcomes, said doctors in a panel discussion this week. But pandemic challenges linger.